Human Noggin recombinant protein

Human Noggin recombinant protein

• DataSheet
• Material Safety Data Sheets (MSDS)

Noggin is a secreted protein involved at multiple stages of vertebrate embryonic development including neural induction and is known to exert its effects by inhibiting the bone morphogenetic protein (BMP)-signaling pathway. It binds several BMPs with very high (picomolar) affinities, with a marked preference for BMP2 and BMP4 over BMP7. By binding tightly to BMPs, Noggin prevents BMPs from binding their receptors. Noggin binds the bone morphogenetic proteins (BMP) such as BMP-4 and BMP-7, and inhibits BMP signaling by blocking the molecular interfaces of the binding epitopes for both type I and type II receptors. Interaction of BMP and its antagonist Noggin governs various developmental and cellular processes, including embryonic dorsal-ventral axis, induction of neural tissue, formation of joints in the skeletal system and neurogenesis in the adult brain. Noggin plays a key role in neural induction by inhibiting BMP4, along with other TGF-β signaling inhibitors such as chordin and follistatin. Mouse knockout experiments have demonstrated that noggin also plays a crucial role in bone development, joint formation, and neural tube fusion.

Noggin

SYNS1; SYM1; RP23-205A9.1; NOGGIN; NOG

Q13253

NOG

Human Cells

A DNA sequence encoding the human NOG (NP_005441.1) (Met1-Cys232) was expressed with five amino acids (DDDDK) at the C-terminus.

Human

The recombinant human NOG consists 211 amino acids and predicts a molecular mass of 23.7 kDa.

> 85 % as determined by SDS-PAGE.

Measured by its ability to inhibit BMP4 induced alkaline phosphatase production by MC3T3-E1 cells.
The ED₅₀ for this effect is typically 0.18-0.7 ug/mL in the presence of 50 ng/mL of hBMP4.